IsoPlexis Corp

IsoPlexis — Merger or Acquisition (February 2023)

6 slides from IsoPlexis's merger presentation, Feb 7, 2023

  1. Slide 1: BLI Leadership Team With Deep Life Science Experience

    BLI Leadership Team With Deep Life Science Experience Winning culture a = = eee Siddhartha Kadia, Ph.D. Mehul Joshi Customer Centricity Chief Executive Officer Chief Financial Officer Chief Business Officer eo } Continuing Innovation eee j Commitment to a eee Rolando Brawer, Ph.0. Excellence in Qual

  2. Slide 2: Integration Planning for PhenomeX

    INTEGRATION PLANNING FOR PhenomexX A PREMIER FUNCTIONAL CELL BIOLOGY ‘COMPANY

  3. Slide 3: Three- to five-year strategic operating plan

    Three- to five-year strategic operating plan IGi Generate positive operating cash flow Deliver consistent commercial execution Prioritize R&D return on investment Build a world- class team with a proven track record in profitably scaling life sciences tools and services companies through increased f

  4. Slide 4: Timeline

    Timeline , We are here. PhenomexX Deal Signing Z Day 1 Financials SEC Review Shareholder Vote ‘Company Confidential, For internal Use Only.

  5. Slide 5: The blueprint for PhenomeX

    The blueprint for PhenomeX Create a Premier Functional Cell Biology Company © Building a world-class team with focus on PhenomeX commercial channel * Innovation engine to create the best product pipeline * Path to ~$300M in revenue by 2027 A Growing, Profitable, & Sustainable Company * Cashflow posi

  6. Slide 6: Forward-Looking Statements

    Forward-Looking Statements Certain statements in this communication regarding the proposed transaction between Berkeley Lights and IsoPlexis, the expected timetable for completing the transaction, benefits and synergies of the transaction, future opportunities for the combined company and products a

IsoPlexis — Merger or Acquisition (February 2023) on 6ix